Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price target. The positive stance comes as the company plans to launch Bolt’s laser-based intravascular lithotripsy (IVL) system for peripheral use in late 2025. Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity Image: Courtesy of Boston Scientific The company has already c ...